logo


FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:February 28, 2011
Estimated average burden
hours per response0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
WYGOD MARTIN J
(Last)(First)(Middle)
669 RIVER DRIVE, CENTER 2
(Street)
ELMWOOD PARKNJ07407
(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
HLTH CORP [HLTH]		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chmn of the Board & Acting CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code
(Instr. 8)		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 10/23/2009 D  6,818,532 (1) D (2) 0 D  
Common Stock 10/23/2009 D  5,000 D (2) 0 I By Spouse - in IRA
Common Stock 10/23/2009 D  161,332 D (2) 0 I By SYNC, Inc.
Common Stock 10/23/2009 D  236 D (2) 0 I By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date
(Month/Day/Year)		7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) $ 10 10/23/2009 D   25,000 10/23/200907/03/2010 Common Stock 25,000 (3) 0 D  
Stock Option (right to buy) $ 14.8 10/23/2009 D   25,000 10/23/200907/01/2011 Common Stock 25,000 (4) 0 D  
Stock Option (right to buy) $ 15.5 10/23/2009 D   25,000 10/23/200907/01/2012 Common Stock 25,000 (5) 0 D  
Stock Option (right to buy) $ 22.9 10/23/2009 D   25,000 10/23/200907/01/2013 Common Stock 25,000 (6) 0 D  
Stock Option (right to buy) $ 12.75 10/23/2009 D   3,000,000 10/23/200908/21/2010 Common Stock 3,000,000 (7) 0 D  
Stock Option (right to buy) $ 8.77 10/23/2009 D   375,000  (8)01/27/2016 Common Stock 375,000 (9) 0 D  
Stock Option (right to buy) $ 8.77 10/23/2009 D   100,000  (8)01/27/2016 Common Stock 100,000 (10) 0 D  
Stock Option (right to buy) $ 11.86 10/23/2009 D   900,000 10/23/200910/23/2016 Common Stock 900,000 (11) 0 D  
Stock Option (right to buy) $ 8.49 10/23/2009 D   480,000  (8)12/01/2018 Common Stock 480,000 (12) 0 D  
Explanation of Responses:
1. Includes 360,000 shares of Restricted Stock.
2. Pursuant to the terms of the merger agreement ("Merger Agreement") between HLTH Corporation ("HLTH") and WebMD Health Corp. ("WebMD") dated June 17, 2009, each share of HLTH common stock was automatically converted into .4444 shares of WebMD common stock on the effective date of the merger.
3. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 11,110 shares of WebMD common stock with an exercise price of $22.51 per share.
4. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 11,110 shares of WebMD common stock with an exercise price of $33.31 per share.
5. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 11,110 shares of WebMD common stock with an exercise price of $34.88 per share.
6. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 11,110 shares of WebMD common stock with an exercise price of $51.54 per share.
7. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 1,333,200 shares of WebMD common stock with an exercise price of $28.70 per share.
8. 25% of the shares underlying the options vested or are scheduled to vest on each of the first, second, third, and fourth grant date anniversaries. The date of grant for each of these options was ten years prior to the expiration date.
9. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 166,650 shares of WebMD common stock with an exercise price of $19.74 per share.
10. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 44,440 shares of WebMD common stock with an exercise price of $19.74 per share.
11. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 399,960 shares of WebMD common stock with an exercise price of $26.69 per share.
12. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 213,312 shares of WebMD common stock with an exercise price of $19.11 per share.
/s/ Lewis H. Leicher, Attorney-in-Fact for Martin J. Wygod10/26/2009
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Add to Delicious   Add to DeliciousDigg It  Digg It
Send Email Send by Email Send Email Post Comment

 
Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

copryright 2009 all rights reserved
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia